Drug Database
S01 OPHTHALMOLOGICALS
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- S01AA01 chloramphenicol
- S01AA11 gentamicin
- S01AA13 fusidic acid
- S01AA23 netilmicin
- S01AA26 azithromycin
- S01AA27 cefuroxime
- S01AD03 aciclovir
- S01AD09 ganciclovir
- S01AE01 ofloxacin
- S01AE03 ciprofloxacin
- S01AE05 levofloxacin
- S01AE07 moxifloxacin
- S01AX15 propamidine
- S01AX18 povidone-iodine
- S01BA01 dexamethasone
- S01BA02 hydrocortisone
- S01BA04 prednisolone
- S01BA06 betamethasone
- S01BA07 fluorometholone
- S01BA14 loteprednol
- S01BA15 fluocinolone acetonide
- S01BC03 diclofenac
- S01BC04 flurbiprofen
- S01BC05 ketorolac
- S01BC10 nepafenac
- S01BC11 bromfenac
- S01CA01 dexamethasone and antiinfectives
- S01EA03 apraclonidine
- S01EA05 brimonidine
- S01EB01 pilocarpine
- S01EB09 acetylcholine
- S01EC01 acetazolamide
- S01EC03 dorzolamide
- S01EC04 brinzolamide
- S01EC54 brinzolamide, combinations
- S01ED01 timolol
- S01ED02 betaxolol
- S01ED03 levobunolol
- S01ED51 timolol, combinations
- S01EE01 latanoprost
- S01EE03 bimatoprost
- S01EE04 travoprost
- S01EE05 tafluprost
- S01EE51 latanoprost and netarsudil
- S01FA01 atropine
- S01FA04 cyclopentolate
- S01FA06 tropicamide
- S01FA56 tropicamide, combinations
- S01FB01 phenylephrine
- S01FB51 phenylephrine and ketorolac
- S01GA51 naphazoline, combinations
- S01GA53 xylometazoline, combinations
- S01GX01 cromoglicic acid
- S01GX05 lodoxamide
- S01GX07 azelastine
- S01GX08 ketotifen
- S01GX09 olopatadine
- S01GX10 epinastine
- S01HA02 oxybuprocaine
- S01HA03 tetracaine
- S01HA04 proxymetacaine
- S01JA01 fluorescein
- S01JA51 fluorescein, combinations
- S01LA01 verteporfin
- S01LA04 ranibizumab
- S01LA05 aflibercept
- S01LA06 brolucizumab
- S01LA09 Faricimab
- S01XA08 acetylcysteine
- S01XA18 ciclosporin
- S01XA19 limbal stem cells, autologous
- S01XA20 artificial tears and other indifferent preparations
- S01XA21 mercaptamine
- S01XA22 ocriplasmin
- S01XA27 voretigene neparvovec
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).